Novel Nasal Saline Irrigation System Improves Compliance, Allergic Rhinitis Symptoms
Study authors evaluated the impact on compliance and SNOT-20 scores in patients with allergic rhinitis using a novel sinus nasal rinse device.
Allergic Disorders
Many With Food Allergy Unaware of Oral Immunotherapy Option
Awareness disproportionately higher among wealthier, more highly educated respondents
Allergic Reactions to mRNA COVID-19 Vaccines Characterized
20 of 22 patients with suspected allergic reactions were women; 17 met Brighton anaphylaxis criteria
mRNA COVID-19 Vaccines Immunogenic in Immunosuppressed Patients
Titers of anti-S IgG lower for patients with chronic inflammatory disease receiving glucocorticoids or B-cell depletion therapy
Most Highly Allergic People Can Be Safely Immunized Against COVID-19
Algorithm enables immunization of most individuals, with 0.7 percent developing anaphylactic reaction after one BNT162b2 dose
Anaphylaxis Risk Compared for Monoclonal Antibodies Used for Severe Asthma
Data mining resulted in 2006 reports of anaphylaxis related to the use of 5 mAbs.
Oral Transglutaminase 2 Inhibitor Beneficial in Celiac Disease
ZED1227 attenuates gluten-induced duodenal mucosal damage among patients undergoing daily gluten challenge
FDA Approves Rx-to-OTC Switch for Astepro Allergy Nasal Spray
The FDA has approved a prescription to over-the-counter (OTC) switch for Astepro® Allergy (azelastine hydrochloride nasal spray, 0.15%).
Etrasimod Granted Orphan Drug Status for Eosinophilic Esophagitis
Etrasimod is an investigational, next generation, once-daily, oral, highly selective sphingosine 1-phosphate receptor modulator.
Drug-Induced Immunosuppression Examined in US Adults
Drug-induced immunosuppression, particularly from oral corticosteroids, may limit response to COVID-19 vaccine
